Irish Examiner on MSN2mon
MSD acquires WuXi's vaccine facility in Dundalk for €500m
China's WuXi Biologics is to sell its vaccine manufacturing site in Dundalk to MSD Ireland in a €500m deal. The acquisition ...
pharmaphorum2mon
MSD buys Irish vaccines plant from WuXi for €500m
MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...
GlobalData on MSN2mon
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for ...